Literature DB >> 11009105

Interleukin-4 transgenic mice develop glomerulosclerosis independent of immunoglobulin deposition.

B M Rüger1, K J Erb, Y He, J M Lane, P F Davis, Q Hasan.   

Abstract

Mice with constitutive transgenic (tg) expression of IL-4 develop autoimmune-type disorders resembling human lupus nephritis. The kidneys show progressive glomerulosclerosis with immunoglobulin (Ig) and complement deposition. This study investigated the roles of renal IL-4 expression and glomerular Ig deposition in the pathogenesis of glomerulosclerosis in IL-4 tg mice. Treatment of these mice with IL-4 neutralizing antibody prevented renal disease. IL-4 tg mice treated with methylprednisolone (MP) showed increased mesangial collagen deposition with only trace amounts of glomerular Ig. To analyze the relevance of Ig deposition in the development of the renal lesions, IL-4 tg mice were cross-bred with mu chain-deficient mice (muMT-/-), which are unable to produce Ig. IL-4 tg/muMT-/- mice developed progressive glomerulosclerosis with mesangial accumulation of collagen types I, IV and V despite complete absence of glomerular Ig deposits. Renal IL-4 expression was observed in both anti-IL-4- and MP-treated IL-4 tg mice as well as in IL-4 tg/muMT-/- mice. No statistical difference in the number of glomerular T cells and macrophages between any of the groups was evident. Our data demonstrate that in this model glomerulosclerosis can develop independently of and prior to Ig deposition, and suggest that the initial accumulation of glomerular extracellular matrix is due to renal IL-4 expression. Our results point to a novel mechanism for the development of glomerulosclerosis which may have implications for human disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11009105     DOI: 10.1002/1521-4141(200009)30:9<2698::AID-IMMU2698>3.0.CO;2-1

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis.

Authors:  Ram Raj Singh; Vijay Saxena; Song Zang; Lily Li; Fred D Finkelman; David P Witte; Chaim O Jacob
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

2.  B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement.

Authors:  Alfred Hj Kim; Jun-Jae Chung; Shreeram Akilesh; Ania Koziell; Sanjay Jain; Jeffrey B Hodgin; Mark J Miller; Thaddeus S Stappenbeck; Jeffrey H Miner; Andrey S Shaw
Journal:  JCI Insight       Date:  2017-11-02

3.  An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis.

Authors:  Deijanira Alves De Albuquerque; Vijay Saxena; David E Adams; Gregory P Boivin; Hermine I Brunner; David P Witte; Ram Raj Singh
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

4.  Interleukin-6 expands homeostatic space for peripheral T cells.

Authors:  Changwan Hong; Anna S Nam; Hilary R Keller; Davinna L Ligons; Joo-Young Park; Hee-Won Yoon; Joseph J Park; Megan A Luckey; Jung-Hyun Park
Journal:  Cytokine       Date:  2013-08-26       Impact factor: 3.861

Review 5.  Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models.

Authors:  Simanta Pathak; Chandra Mohan
Journal:  Arthritis Res Ther       Date:  2011-09-30       Impact factor: 5.156

Review 6.  Lupus nephritis: current update.

Authors:  Ramesh Saxena; Tina Mahajan; Chandra Mohan
Journal:  Arthritis Res Ther       Date:  2011-09-28       Impact factor: 5.156

7.  Ginsenoside Rh1 Improves the Effect of Dexamethasone on Autoantibodies Production and Lymphoproliferation in MRL/lpr Mice.

Authors:  Yinglu Feng; Chunbin Wang; Silu Cheng; Xiaorong Wang; Xianze Meng; Lujia Li; Juan Du; Qun Liu; Yuyu Guo; Yongbin Meng; Binbin Cheng; Changquan Ling
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-31       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.